Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

NAMS.US Logo

NAMS.US - Current Price

$32.69

Company Information

▼
Company Name
NewAmsterdam Pharma Company N.V. Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: NL00150012L7
CIK: 0001936258
Currency: USD
Full Time Employees: 68
Phone: 31 35 206 2971
Website: https://www.newamsterdampharma.com
Fiscal Year End: December
IPO Date: Nov 23, 2022
Description:

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Address:

Gooimeer 2-35, Naarden, Netherlands, 1411 DC

Directors & Officers

▼
Name Title Year Born
Dr. Michael Harvey Davidson FACC, Facp., M.D. CEO, President & Executive Board Member 1956
Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D. Founder, Chief Scientific Officer, Member of Executive Board & Director 1954
Mr. Mayur Amrat Somaiya Chief Financial Officer 1974
Mr. Douglas F. Kling Chief Operating Officer 1973
Ms. Juliette Audet M.B.A., M.Sc. Chief Strategy & Business Officer 1987
Ms. Louise Kooij Chief Accounting Officer 1976
Mr. Matthew Philippe Executive VP &Head of Investor Relations NA
Mr. Bob Rambo Executive Vice President of Marketing NA
Ms. Maryellen McQuade Chief People Officer NA
Dr. Marc Ditmarsch M.D. Chief Development Officer 1967

Shares Statistics

▼
Shares Outstanding: 113.39M
Shares Float: 62.48M
% Insiders: 38.30%
% Institutions: 10,601.10%
Short % Float: 6.53%

Valuation Metrics

▼
Enterprise Value: $3.00B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $3.71B
EBITDA: $-202.72M
Book Value: $6.43
Earnings/Share: $-2.04
Profit Margin: 0.00%
Operating Margin: -15,845.69%
ROA (TTM): -20.70%
ROE (TTM): -39.94%
Revenue (TTM): $35.24M
Revenue/Share (TTM): $0.31
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -98.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 0.00 -0.47 N/A 10,000.00%
Dec 31, 2025 0.00 -0.40 N/A 10,000.00%
Sep 30, 2025 -0.61 -0.40 N/A -5,125.22%
Jun 30, 2025 -0.15 -0.44 N/A 6,590.91%
Mar 31, 2025 -0.30 -0.44 N/A 3,181.82%
Dec 31, 2024 -0.93 -0.96 N/A 312.50%
Sep 30, 2024 -0.16 -0.45 N/A 6,444.44%
Jun 30, 2024 -0.38 -0.52 N/A 2,692.31%
Mar 31, 2024 -0.99 -0.48 N/A -10,625.00%
Dec 31, 2023 -0.54 -0.55 N/A 181.82%
Sep 30, 2023 -0.56 -0.76 N/A 2,576.32%
Jun 30, 2023 -1.01 -0.42 N/A -14,047.62%
Mar 31, 2023 -0.44 -0.44 N/A 111.36%
Dec 31, 2022 -1.80 -0.49 N/A -26,734.69%
Sep 30, 2022 -0.27 -1.14 N/A 7,637.72%
Jun 30, 2022 -0.07 N/A N/A N/A
Mar 31, 2022 0.08 N/A N/A N/A
Dec 31, 2021 0.05 N/A N/A N/A
Sep 30, 2021 0.10 N/A N/A N/A
Jun 30, 2021 -0.07 N/A N/A N/A
Mar 31, 2021 0.16 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $771.74M $N/A $864.62M $107.12M $757.50M
2023-12-31 $340.45M $N/A $347.10M $58.70M $288.39M
2022-12-31 $467.73M $N/A $478.50M $48.43M $430.07M
2021-12-31 $60.38M $N/A $67.99M $11.36M $56.63M
2020-12-31 $1.37M $N/A $139.87M $12.41M $127.46M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 15, 2025 N/A N/A N/A N/A N/A N/A
Sep 09, 2025 N/A N/A N/A N/A N/A N/A
Sep 08, 2025 N/A N/A N/A N/A N/A N/A
Sep 03, 2025 N/A N/A N/A N/A N/A N/A
Aug 25, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 11, 2025 N/A N/A N/A N/A N/A N/A
Jul 16, 2025 N/A N/A N/A N/A N/A N/A
Jul 15, 2025 N/A N/A N/A N/A N/A N/A
Jun 25, 2025 N/A N/A N/A N/A N/A N/A
Jun 24, 2025 N/A N/A N/A N/A N/A N/A
Jun 16, 2025 N/A N/A N/A N/A N/A N/A
Jun 16, 2025 N/A N/A N/A N/A N/A N/A
Mar 26, 2025 N/A N/A N/A N/A N/A N/A
Mar 04, 2025 N/A N/A N/A N/A N/A N/A
Mar 04, 2025 N/A N/A N/A N/A N/A N/A
Dec 30, 2024 N/A N/A N/A N/A N/A N/A
Dec 26, 2024 N/A N/A N/A N/A N/A N/A
Dec 23, 2024 N/A N/A N/A N/A N/A N/A
Dec 20, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist